John A. Reeves

Radium-223 in asymptomatic patients with castration-resistant prostate cancer and bone metastases treated in an international early access program

Axel Heidenreich, Silke Gillessen, Daniel Heinrich et al. · BMC Cancer · 2019 · 51 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Disease Characteristics and Completion of Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer Treated With Radium-223 in an International Early Access Program

Fred Saad, Silke Gillessen, Daniel Heinrich et al. · Clinical Genitourinary Cancer · 2019 · 36 citations · Full text

Medicine, Oncology, Radiation Oncology +17

1916P Larotrectinib treatment of advanced TRK fusion thyroid cancer

Maria E. Cabanillas, Alexander Drilon, Anna F. Farago et al. · Annals of Oncology · 2020 · 33 citations

Medicine, Oncology, Surgery +9

Larotrectinib versus Prior Therapies in Tropomyosin Receptor Kinase Fusion Cancer: An Intra-Patient Comparative Analysis

Antoîne Italiano, Shivani Nanda, Andrew Briggs et al. · Cancers · 2020 · 23 citations · Full text

Medicine, Oncology, Pharmacology +17

1955P Survival benefits of larotrectinib in an integrated dataset of patients with TRK fusion cancer

Ray McDermott, Cornelis M. van Tilburg, Anna F. Farago et al. · Annals of Oncology · 2020 · 17 citations

Medicine, Oncology, Pharmacology +16